The current aims of bi- sphosphonates for metastatic bone disease are to prevent skeletal-related events, reduce bone pain, and improve quality of life.
目前双膦酸盐类药物治疗骨转移的主要目的是减少骨相关事件、减轻疼痛和提高生活质量。
The symptoms of bone pain and osteoporosis improved.
骨痛、骨质疏松症状明显改善。
Primary lymphoma of bone manifests with insidious and intermittent bone pain present for months.
骨原发性淋巴瘤常见症状为隐匿性、间歇性疼痛,病程可达数月。
In acute lymphocytic leukemia, bone pain occurs in approximately 25% of patients at the onset of the disease.
急性淋巴细胞白血病患者中,大概只有25%的人在初期会感受到骨骼处产生的疼痛。
Conclusion: Ibandronate can effectively relieve bone pain caused by Multiple Myeloma and drop serum calcium, to treat hypercalcemia.
结论:伊班膦酸钠能有效缓解多发性骨髓瘤患者骨痛,降低血钙,治疗高钙血症。
The rates of bone pain and influenza symptom were 21% and 16%, respectively. Local response of injection and rash, fever were infrequent.
骨痛和感冒症状发生率分别为21%和16%,注射部位局部反应、皮疹、发热少见。
AIM: to evaluate the efficacy of Ibandronate in relieving bone pain and the tolerability in malignant tumor patients with bone metastases.
目的:评价伊班磷酸钠治疗恶性肿瘤骨转移引起的骨痛及其不良反应。
Objective to investigate the diagnostic value of bone imaging for bone pain of unknown cause and the common diseases that caused the symptoms.
目的探讨骨显像对不明原因骨痛病人的诊断价值及引起骨痛的常见疾病。
Conclusion Bonin, as a safe and effective Bisphosphonates preparation, could relieve bone pain in multiple myeloma more effectively when combined with chemotherapy.
结论博宁是一种安全有效的双膦酸盐制剂,与化疗联合应用可以显著缓解多发性骨髓瘤患者的骨痛。
ObjectiveTo observe the effects of long-term and low-dose hormone replacement therapy on bone mineral density (BMD), and the incidence of bone pain in postmenopausal women.
目的观察长期应用小剂量性激素替代疗法对绝经后妇女骨密度及骨关节痛发生的影响。
Bone pain may occur in the absence of a pathological fracture or vertebral collapse, but it becomes worse when this occurs.
骨痛在没有病理性骨折或脊椎塌陷的情况下也会发生,但在这两种情况发生时变得更为严重。
METHODS: All 68 patients were treated with ibandronate during the intermission of chemotherapy. Bone pain, ADL, bone metastasis focus, change of serum Ca2 + level and side effect were observed.
方法:在化疗间歇期应用伊班膦酸钠治疗骨转移癌患者68例,观察骨痛、活动能力、骨转移病灶、血钙变化及不良反应。
METHODS: All 68 patients were treated with ibandronate during the intermission of chemotherapy. Bone pain, ADL, bone metastasis focus, change of serum Ca2 + level and side effect were observed.
方法:在化疗间歇期应用伊班膦酸钠治疗骨转移癌患者68例,观察骨痛、活动能力、骨转移病灶、血钙变化及不良反应。
应用推荐